Daunorubicin 20mg (Daunorubicin Hydrochloride Vials) 20mg

Daunorubicin 20mg is an antineoplastic agent supplied as 20mg vials for intravenous use. This chemotherapy medication is used to treat certain cancers by slowing or stopping cancer cell growth. Store at ambient temperature and follow handling guidelines for cytotoxic drugs.

Strength

20mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Meiji Seika Japan

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Daunorubicin 20mg is primarily used to treat acute myeloid leukemia and acute lymphocytic leukemia. It may also be used in combination therapies for other cancers such as neuroblastoma. This medication works by interfering with cancer cell DNA replication. Patients often ask, what is daunorubicin used for in cancer treatment?

Side Effects

Daunorubicin 20mg may cause temporary hair loss, nausea, or fatigue as common effects. Some patients report changes in urine color shortly after administration. These effects vary by individual and treatment protocol. Always discuss persistent symptoms with a healthcare provider.

Precautions & Warnings

Daunorubicin 20mg is a cytotoxic drug that requires careful handling to avoid exposure. Use protective gloves and dispose of waste according to medical waste guidelines. Keep out of reach of children and pets. Inform healthcare providers about all current medications and medical conditions before use.

Avoid Interactions

Daunorubicin 20mg may interact with other chemotherapy drugs, radiation therapy, or medications affecting the heart. Alcohol and certain herbal supplements may increase side effects. CYP450 inhibitors or inducers could alter drug metabolism. Always disclose all medications to your healthcare provider.

References

Frequently Asked Questions

It is used to treat certain types of leukemia and neuroblastoma as part of chemotherapy regimens.

It is given by intravenous injection or infusion by healthcare professionals in a clinical setting.

This medication is available by prescription only and requires professional medical supervision.

Common effects include nausea, fatigue, and temporary hair loss, though individual responses vary.

Yes, it is a chemotherapy medication classified as an anthracycline antineoplastic agent.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.